{
  "resourceType": "RiskAssessment",
  "id": "mii-exa-molgen-prs-brca1",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/polygener-risiko-score|2026.0.2"
    ]
  },
  "prediction": [
    {
      "extension": [
        {
          "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/risk-assessment-einflussfaktor",
          "valueCodeableConcept": {
            "coding": [
              {
                "code": "414152003",
                "system": "http://snomed.info/sct",
                "display": "European (ethnic group)"
              }
            ],
            "text": "Der verwendete Polygene Risikoscore wurde bisher nur für die europäische Bevölkerung bei Brustkrebs validiert."
          }
        }
      ],
      "outcome": {
        "coding": [
          {
            "code": "718220008",
            "system": "http://snomed.info/sct",
            "display": "Hereditary breast and ovarian cancer syndrome (disorder)"
          }
        ]
      },
      "qualitativeRisk": {
        "coding": [
          {
            "code": "high",
            "system": "http://terminology.hl7.org/CodeSystem/risk-probability",
            "display": "High likelihood"
          }
        ]
      }
    }
  ],
  "status": "final",
  "subject": {
    "reference": "Patient/mii-exa-molgen-patient-2"
  },
  "occurrenceDateTime": "2022-11-01",
  "basis": [
    {
      "reference": "Observation/mii-exa-molgen-variante-brca1"
    }
  ]
}
